Covered recipient · General Payments record
MATTHEW MARR
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$10,223.71
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,722.09 | 4 |
| Food and Beverage | $1,339.25 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AXOGEN | $1,924.53 | 8 |
| Arthrex, Inc. | $450.99 | 1 |
| Kerecis Limited | $320.06 | 1 |
| Endo USA, Inc. | $157.17 | 3 |
| Integra LifeSciences Corporation | $156.28 | 1 |
| Myriad Genetic Laboratories, Inc. | $19.93 | 1 |
| Endo Pharmaceuticals Inc. | $17.38 | 1 |
| Alpha Orthopedic Systems | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alpha Orthopedic Systems | $15.00 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089078960 | CMS |
| Arthrex, Inc. | $450.99 | 02/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1146570861 | CMS |
| AXOGEN | $135.42 | 03/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143644612 | CMS |
| AXOGEN | $51.18 | 03/24/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143644628 | CMS |
| AXOGEN | $603.22 | 03/24/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143644630 | CMS |
| AXOGEN | $181.31 | 03/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143644632 | CMS |
| AXOGEN | $616.70 | 03/24/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143644634 | CMS |
| AXOGEN | $128.26 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143642145 | CMS |
| AXOGEN | $128.75 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143643069 | CMS |
| AXOGEN | $79.69 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143643970 | CMS |
| Endo Pharmaceuticals Inc. | $17.38 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137015846 | CMS |
| Endo USA, Inc. | $10.18 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138584370 | CMS |
| Endo USA, Inc. | $126.69 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138584372 | CMS |
| Endo USA, Inc. | $20.30 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138584374 | CMS |
| Integra LifeSciences Corporation | $156.28 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140116934 | CMS |
| Kerecis Limited | $320.06 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120115932 | CMS |
| Myriad Genetic Laboratories, Inc. | $19.93 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152535849 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.